Previous close | 0.3300 |
Open | 0.3300 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 190.00 |
Expiry date | 2022-11-18 |
Day's range | 0.3300 - 0.3300 |
Contract range | N/A |
Volume | |
Open interest | 169 |
You'll need to hold these stocks for many years to get the full benefit of their consistent dividend growth.
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), invites consumers to experience the JUVÉDERM® difference. The JUVÉDERM® Collection of Fillers is the number one selling collection of dermal fillers on the market and offers the largest portfolio of fillers specifically designed for different areas of the face to address key patient concerns, enabling a customized treatment approach.1 Injectable dermal fillers are highly sought-after treatments among consumers who are looking to address key si
Roche's (RHHBY) sBLA seeking approval for the use of Polivy in combination with R-CHP for previously untreated diffuse large B-cell lymphoma in adults has been accepted in the United States.